Supplements for Cardiovascular Health


Omega-3 Heart Health

OmegaBrite© can positively impact Hearth Health in cases of Heart Attacks and Heart Disease among others.

Omega-3 Heart Health

The American Heart Association recognizes the importance of the omega-3’s essential nutrients EPA and DHA in promoting cardiac health, lowering blood triglycerides and in protecting against cardiovascular disease. The high EPA Omega-3 in OmegaBrite provides important anti-inflammatory protection for heart and overall health. The American Heart Association recommends two fish meals a week and says that a 0.5-1.8 grams of Omega-3 per day can be beneficial. Those with heart disease may need more than 1 gram per day and may find it beneficial to increase their dosage to 2-4 grams OmegaBrite per day with medical supervision.

The American Heart Association has also issued new recommendations for women with hypercholesterolemia or hypertriglyceridemia. The AHA says that women with those conditions may benefit from 1800 mg of EPA per day. This recommendation is supported from research in the JELIS study that shows that even in those individuals eating a high fish diet, on statins, taking 1800 mg EPA Omega-3 supplement further improves cardiac health. For those individuals who are on a statin therapy, a study published in the American Journal of Cardiology in August 2006 recommends that all individuals on a statin also benefit from taking an Omega-3.

Our Products

Receive a 10% discount with AutoRefill

Related Testimonials

  • My daughter was diagnosed with ADD since she was in the 3rd grade. We would both end up crying every night with homework and just her everyday struggles with not retaining things, impulsiveness and her attitude in general. Her doctor suggested OmegaBrite and she is off to a wonderful start…
    Vickie P.


Fish oils help prevent stroke and heart attacks, Thies, Frank, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. The Lancet, Vol. 361, February 8, 2003, pp. 477-85

Older people benefit from fish oils, Lemaitre, RN, et al. n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. American Journal of Clinical Nutrition, Vol. 77, February 2003, pp. 319-25, Harris, WS. n-3 long-chain polyunsaturated fatty acids reduce risk of coronary heart disease death: extending the evidence to the elderly. American Journal of Clinical Nutrition, Vol. 77, February 2003, pp. 279-80 (editorial)

Daviglus M, M.D,Ph.D., et al., “Fish Consumption and the 30-year Risk of Fatal Myocardial Infarction” The New England Journal of Medicine, 1997 v.336 (15) 1046-1053

Essential Fatty Acids Reduce the Risk of Myocardial Infarction, Source: January 2003 issue of The American Journal of Clinical Nutrition (77, 1:37-42, 2003) (

Oxidized omega-3 fatty acids in fish oil inhibit leukocyte-endothelial interactions through activation of PPAR alpha., Sethi S, Ziouzenkova O, Ni H, Wagner DD, Plutzky J, Mayadas TN. Vascular Research Division, Department of Pathology, Brigham and Women’s Hospital and Center for Blood Research, Harvard Medical School, Boston, MA 02130, USA.

Fish consumption reduces heart disease risk, Torres, Isabel C., et al. Study of the effects of dietary fish intake on serum lipids and lipoproteins in two populations with different dietary habits. British Journal of Nutrition, Vol. 83, 2000, pp. 371

Harris, S William “n-3 Fatty Acids and Serum Lipoproteins:, Human Studies,” Am J Clin Nutr Vol. 65 pp. 154-164 1997.

Increased fish intake combats heart disease DALLAS, TEXAS., Krauss, Ronald M., et al. AHA Dietary Guidelines – Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation, Vol. 102, October 31, 2000, pp. 2284-99


Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione., Author: Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F. Source: Circulation. 2002 Apr 23;105(16):1897-903.

Ogita, H., K. Node, et al. (2003). “Eicosapentaenoic acid reduces myocardial injury induced by ischemia and reperfusion in rabbit hearts.” J Cardiovasc Pharmacol 41(6): 964-9.

Nyby, M. D., M. T. Hori, et al. (2003). “Eicosapentaenoic acid inhibits Ca2+ mobilization and PKC activity in vascular smooth muscle cells.” Am J Hypertens 16(9 Pt 1): 708-14.

von Schacky, Clemens, MD, “The Effect of Dietary Omega-3 Fatty Acids on Coronary Atherosclerosis,” Annals of Internal Medicine, Volume 130, Number 7, April 6, 1999, 554562.

Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women, Author: Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE., Source: JAMA. 2002 Apr 10;287(14):1815-2

Fish Oils and Atherosclerosis, Reference: von Schacky, Clemens, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. Annals of Internal Medicine, Vol. 130, April 6, 1999, pp. 554-62 Co sponsor:Pronova A.S

Am J Cardiol. 2006 Aug 21;98(4A):61i-70i. Epub 2006 May 30., Secondary prevention of coronary artery disease with omega-3 fatty acids., Jacobson TA., Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University School of Medicine, Atlanta, Georgia 30303, USA.

Am J Cardiol. 2006 Aug 21;98(4A):50i-60i. Epub 2006 May 26., Antiarrhythmic effects of omega-3 fatty acids., Reiffel JA, McDonald A., Division of Cardiology, Department of Medicine, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York 10032, USA.

Cardiovasc Res. 2007 Jan 15;73(2):310-5. Epub 2006 Sep 1., Cardiovascular benefits of omega-3 fatty acids., von Schacky C, Harris WS., Medizinische Klinik und Poliklinik Innenstadt, Ludwig Maximilians-Universitat Munchen, Ziemssenstrasse 1, D-80336 Munich, Germany.

Lancet. 2007 Mar 31;369(9567):1090-8., Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis., Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA lipid intervention study (JELIS) Investigators., Kobe University, Kobe, Japan.

Curr Vasc Pharmacol. 2008 Jan;6(1):1-12., Fish oil Fatty acids as cardiovascular drugs., Leaf A, Kang JX, Xiao YF., Departments of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Clin Nutr. 2008 Jan 29 [Epub ahead of print], Omega-3 polyunsaturated fatty acid in peripheral arterial disease: Effect on lipid pattern, disease severity, inflammation profile, and endothelial function., Schiano V, Laurenzano E, Brevetti G, De Maio JI, Lanero S, Scopacasa F, Chiariello M., Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples Federico II, Naples, Italy.

Kurinami Shigeru Kumagai, Naoko Hayashi, Hideki Hayashida, Yoshiko Sato, Masayuki Yamaguchi, Akira Kajiwara, Keizo Nonaka, Kyohei “Effects of Polyunsaturated Fatty Acids and/or Lecithin on the Plasma Concentrations of Very Low Density Lipoprotein-Triglyceride (VLDL) and Ketone Bodies in Humans.” The Kurume Medical Journal. Pp. 7176 Vol. 35 1988., Omega-3 Fatty Acids Help Diabetics Prone to Atherosclerosis

Atherosclerosis. 2007 Dec 24 [Epub ahead of print], Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives., Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ., Nutrition and Metabolic Disease Research, Sanford Research/USD, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, United States.

Am. J. Clin. Nutr. 2007 May;85(5):1222-8., Effects of fish-oil supplementation on myocardial fatty acids in humans., Metcalf RG, James MJ, Gibson RA, Edwards JR, Stubberfield J, Stuklis R, Roberts-Thomson K, Young GD, Cleland LG., Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia.

J Nutr Biochem. 2007 Sep 26; [Epub ahead of print], Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health.,Siddiqui RA, Harvey KA, Zaloga GP., Cellular Biochemistry Laboratory, Methodist Research Institute, Clarian Health, Indianapolis, IN 46202, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

Curr Atheroscler Rep. 2007 Aug;9(2):145-53., Beyond lipids: the role of omega-3 fatty acids from fish oil in the prevention of coronary heart disease., Jacobson TA., Department of Medicine, Emory University, 49 Jesse Hill Jr Drive SE, Atlanta, GA 30303, USA.

Atherosclerosis. 2007 Sep 15; [Epub ahead of print], EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls., Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA., Department of Community and Preventive Medicine, University of Rochester School of Medicine and Dentistry, Rochester, Box 644, 601 Elmwood Avenue, NY 14642, United States.

Ann N Y Acad Sci. 2007 Nov;1114:381-8., Dietary polyunsaturated Fatty acids and age-related membrane changes in the heart., Pepe S., Head, Laboratory of Cardiothoracic Surgical Research, Department of Surgery, Monash University, Alfred Hospital, Melbourne, 3004, Australia.

Curr Vasc Pharmacol. 2007 Apr;5(2):163-172., Cardiovascular Effects of Omega-3 Free Fatty Acids., Biscione F, Pignalberi C, Totteri A, Messina F, Altamura G., Cardiologia-UTIC, Ospedale S. Giacomo, Roma, Italy.

J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S46-9., Cardiovascular risk and the omega-3 index., von Schacky C, Harris WS., Preventive Cardiology, Medizinische Klinik und Poliklinik Innenstadt, Ludwig Maximilians-Universitt Mnchen, Munich, Germany.

MMW Fortschr Med. 2007 Sep 13;149 Suppl 3:97-101., Omega-3 fatty acids in cardiology. Latest developments, von Schacky C., Medizinische Klinik und Poliklinik der Ludwig-Maximilians-Universitt Mnchen und Omegametrix, Martinsried.

J Cardiometab Syndr. 2007 Fall;2(4):244-249., Fatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study., Ebbesson SO, Tejero ME, Nobmann ED, Lopez-Alvarenga JC, Ebbesson L, Romenesko T, Carter EA, Resnick HE, Devereux RB, Maccluer JW, Dyke B, Laston SL, Wenger CR, Fabsitz RR, Comuzzie AG, Howard BV., From Norton Sound Health Corp, Nome, AK; Southwest Foundation for Biomedical Research, San Antonio, TX; IDM Consulting, Anchorage, AK; University of Bergen, Bergen, Norway; MedStar Research Institute, Hyattsville, MD; Cornell Medical Center, New York, NY; Southwest Iconics, San Antonio, TX.